Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Marshall Mohr sold 4,250 shares of the stock in a transaction that occurred on Wednesday, March 15th. The shares were sold at an average price of $750.00, for a total value of $3,187,500.00. Following the sale, the chief financial officer now directly owns 4,422 shares of the company’s stock, valued at approximately $3,316,500. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Marshall Mohr also recently made the following trade(s):
Intuitive Surgical, Inc. (NASDAQ:ISRG) opened at 750.03 on Tuesday. Intuitive Surgical, Inc. has a one year low of $562.60 and a one year high of $755.55. The company has a market cap of $29.09 billion, a P/E ratio of 40.04 and a beta of 0.55. The company’s 50 day moving average price is $722.82 and its 200-day moving average price is $682.63.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, January 24th. The company reported $6.09 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $5.99 by $0.10. Intuitive Surgical had a return on equity of 14.24% and a net margin of 27.21%. The business had revenue of $757 million for the quarter, compared to the consensus estimate of $739.65 million. During the same quarter in the previous year, the company posted $5.89 EPS. The company’s revenue was up 11.9% compared to the same quarter last year. On average, analysts forecast that Intuitive Surgical, Inc. will post $23.49 EPS for the current fiscal year.
A number of hedge funds have recently added to or reduced their stakes in ISRG. Acropolis Investment Management LLC purchased a new stake in Intuitive Surgical during the third quarter worth about $109,000. Bessemer Group Inc. increased its stake in Intuitive Surgical by 96.0% in the fourth quarter. Bessemer Group Inc. now owns 196 shares of the company’s stock worth $124,000 after buying an additional 96 shares during the last quarter. Stephens Inc. AR increased its stake in Intuitive Surgical by 77.1% in the third quarter. Stephens Inc. AR now owns 255 shares of the company’s stock worth $185,000 after buying an additional 111 shares during the last quarter. Bronfman E.L. Rothschild L.P. increased its stake in Intuitive Surgical by 41.8% in the third quarter. Bronfman E.L. Rothschild L.P. now owns 275 shares of the company’s stock worth $199,000 after buying an additional 81 shares during the last quarter. Finally, Stonebridge Capital Management Inc. purchased a new stake in Intuitive Surgical during the third quarter worth about $209,000. 91.16% of the stock is currently owned by institutional investors and hedge funds.
A number of research firms have recently weighed in on ISRG. Canaccord Genuity reissued a “buy” rating on shares of Intuitive Surgical in a research note on Wednesday, January 25th. Bank of America Corp set a $800.00 price objective on Intuitive Surgical and gave the company a “buy” rating in a research note on Tuesday, February 14th. Evercore ISI lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $690.00 price objective for the company. in a research note on Wednesday, January 4th. Wedbush reissued an “outperform” rating and set a $800.00 price objective on shares of Intuitive Surgical in a research note on Saturday, January 14th. Finally, Zacks Investment Research downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, January 17th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and twelve have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $733.43.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.